Foresee Pharmaceuticals Co., Ltd.(TW:6576)
NT$73.10+-0.80 (+1.67%)
TW:6576
Foresee Pharmaceuticals Co., Ltd. financials statements
NT$73.10
At close:+-0.80 (+1.67%)
Foresee Pharmaceuticals Co., Ltd. (6576) Ratios
Foresee Pharmaceuticals Co., Ltd. Ratios
TW:6576's free cash flow for Q2 2026 was NT$24.97M. For the 2026 fiscal year, TW:6576's free cash flow was decreased by NT$-2.17M and operating cash flow was NT$27.14M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.44 | 4.62 | 3.38 | 7.08 | 17.51 |
| Quick Ratio | 2.94 | 4.15 | 3.11 | 5.72 | 17.17 |
| Cash Ratio | 1.67 | 3.48 | 2.14 | 5.34 | 11.71 |
| Solvency Ratio | -2.14 | -1.79 | -1.56 | -1.07 | -1.61 |
| Operating Cash Flow Ratio | -2.94 | -2.99 | -1.89 | -1.81 | -2.87 |
| Short-Term Operating Cash Flow Coverage | -4.28 | -7.57 | -4.44 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 604.93M | NT$ 1.26B | NT$ 973.70M | NT$ 521.62M | NT$ 982.16M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.12 | 0.12 | 0.03 | 0.01 |
| Debt-to-Equity Ratio | 0.25 | 0.16 | 0.18 | 0.05 | 0.01 |
| Debt-to-Capital Ratio | 0.20 | 0.14 | 0.15 | 0.04 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.41 | 1.35 | 1.50 | 1.43 | 1.24 |
| Debt Service Coverage Ratio | -4.00 | -6.15 | -4.73 | -1047.47 | -759.34 |
| Interest Coverage Ratio | -154.90 | -160.97 | -353.68 | -1088.88 | -774.32 |
| Debt to Market Cap | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.53 | 1.94 | 1.82 | 0.35 | 0.15 |
| Net Debt to EBITDA | 0.32 | 1.17 | 0.86 | 1.68 | 1.80 |
| Profitability Margins | |||||
| Gross Profit Margin | 68.22% | 57.27% | 58.44% | 91.53% | 77.46% |
| EBIT Margin | -197.70% | -245.17% | -505.43% | -145.18% | -233.29% |
| EBITDA Margin | -181.90% | -225.94% | -467.68% | -128.22% | -210.52% |
| Operating Profit Margin | -199.95% | -257.90% | -516.63% | -145.18% | -233.29% |
| Pretax Profit Margin | -198.99% | -246.77% | -506.89% | -145.31% | -233.59% |
| Net Profit Margin | -204.78% | -258.20% | -531.33% | -156.76% | -251.86% |
| Continuous Operations Profit Margin | -204.78% | -258.20% | -531.33% | -156.76% | -251.86% |
| Net Income Per EBT | 102.91% | 104.63% | 104.82% | 107.88% | 107.82% |
| EBT Per EBIT | 99.52% | 95.69% | 98.12% | 100.09% | 100.13% |
| Return on Assets (ROA) | -67.40% | -50.07% | -55.67% | -36.24% | -34.68% |
| Return on Equity (ROE) | -95.00% | -67.61% | -83.27% | -51.91% | -43.12% |
| Return on Capital Employed (ROCE) | -84.20% | -61.15% | -72.46% | -37.26% | -33.65% |
| Return on Invested Capital (ROIC) | -69.81% | -55.85% | -62.75% | -36.77% | -33.43% |
| Return on Tangible Assets | -73.64% | -52.96% | -59.74% | -40.64% | -38.30% |
| Earnings Yield | -7.07% | -10.16% | -8.50% | -4.43% | -4.06% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.87 | 11.59 | 2.90 | 18.18 | 2173.36 |
| Payables Turnover | 8.27 | 2.78 | 6.68 | 1.12 | 0.00 |
| Inventory Turnover | 0.95 | 0.97 | 0.64 | 0.14 | 2.05 |
| Fixed Asset Turnover | 2.05 | 1.90 | 1.40 | 2.01 | 2.48 |
| Asset Turnover | 0.33 | 0.19 | 0.10 | 0.23 | 0.14 |
| Working Capital Turnover Ratio | 0.41 | 0.33 | 0.20 | 0.30 | 0.16 |
| Cash Conversion Cycle | 378.24 | 275.24 | 642.24 | 2214.67 | 178.42 |
| Days of Sales Outstanding | 36.99 | 31.50 | 125.96 | 20.08 | 0.17 |
| Days of Inventory Outstanding | 385.37 | 375.17 | 570.91 | 2521.20 | 178.25 |
| Days of Payables Outstanding | 44.13 | 131.44 | 54.63 | 326.61 | 0.00 |
| Operating Cycle | 422.37 | 406.68 | 696.87 | 2541.28 | 178.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.44 | -8.55 | -6.97 | -1.98 | -1.80 |
| Free Cash Flow Per Share | -5.54 | -9.68 | -7.34 | -2.47 | -1.86 |
| Dividend Paid and CapEx Coverage Ratio | -54.34 | -7.53 | -19.18 | -4.02 | -27.91 |
| Capital Expenditure Coverage Ratio | -54.34 | -7.53 | -19.18 | -4.02 | -27.91 |
| Operating Cash Flow Coverage Ratio | -3.63 | -4.51 | -3.89 | -5.64 | -12.82 |
| Operating Cash Flow to Sales Ratio | -1.95 | -2.80 | -4.55 | -0.77 | -0.94 |
| Free Cash Flow Yield | -6.87% | -12.49% | -7.66% | -2.73% | -1.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.14 | -9.85 | -11.77 | -22.59 | -24.62 |
| Price-to-Sales (P/S) Ratio | 28.96 | 25.42 | 62.50 | 35.38 | 62.04 |
| Price-to-Book (P/B) Ratio | 13.43 | 6.66 | 9.80 | 11.72 | 10.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.56 | -8.00 | -13.05 | -36.62 | -63.46 |
| Price-to-Operating Cash Flow Ratio | -14.83 | -9.07 | -13.74 | -45.74 | -65.73 |
| Price-to-Earnings Growth (PEG) Ratio | 0.51 | 2.97 | -0.11 | 1.36 | 6.81 |
| Enterprise Value Multiple | -15.60 | -10.08 | -12.51 | -25.92 | -27.67 |
| Enterprise Value | 12.24B | 9.54B | 11.41B | 10.02B | 13.17B |
| EV to EBITDA | -15.60 | -10.08 | -12.51 | -25.92 | -27.67 |
| EV to Sales | 28.38 | 22.77 | 58.50 | 33.23 | 58.26 |
| EV to Free Cash Flow | -14.27 | -7.17 | -12.22 | -34.40 | -59.59 |
| EV to Operating Cash Flow | -14.53 | -8.12 | -12.85 | -42.96 | -61.73 |
| Tangible Book Value Per Share | 5.28 | 10.79 | 8.78 | 6.52 | 9.82 |
| Shareholders’ Equity Per Share | 6.00 | 11.64 | 9.78 | 7.71 | 11.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | -0.05 | -0.05 | -0.08 | -0.08 |
| Revenue Per Share | 2.78 | 3.05 | 1.53 | 2.55 | 1.90 |
| Net Income Per Share | -5.70 | -7.87 | -8.14 | -4.00 | -4.80 |
| Tax Burden | 1.03 | 1.05 | 1.05 | 1.08 | 1.08 |
| Interest Burden | 1.01 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 2.24 | 2.80 | 4.93 | 2.06 | 2.72 |
| SG&A to Revenue | 0.42 | 0.35 | 0.82 | 0.41 | 0.44 |
| Stock-Based Compensation to Revenue | 0.08 | 0.12 | 0.26 | 0.13 | 0.11 |
| Income Quality | 0.98 | 1.14 | 0.86 | 0.53 | 0.37 |
Currency in TWD
